At the kick-off on June 4th country delegates worked together to ensure that the objectives are met by 2022, to ultimately improve disease prevention, personalised treatment and clinical research. Member States have been working to initiate these efforts through ad-hoc working groups. In the Netherlands the 1+MG-NL mirror group was initiated and coordinated by Health-RI. Until now, this was done without the benefit of a formal coordination project to offer structure and international collaboration. The B1MG project provides the required coordination, support and expertise to move ‘beyond’ the 1M genome target and ‘beyond’ the 21 signatory countries of the original initiative.
B1MG will offer clear guidance to implement personalised medicine, at a local, regional and national scale. Personalised medicine, which considers people’s genetic makeup, can yield notable socio-economic benefits.
B1MG is coordinated by ELIXIR and funded by Horizon 2020
For more information: B1MG press release by Elixir